Healthcare & Medical Investment Corp. Annual Results: Standalone & Consolidated Reports

Annual Results

Results Snapshot

Figures in Million

Consolidate Annual Results

Jul'25

Jul'24

Jul'23

Jul'22

Jul'21

Jul'20

Jul'19

Net Sales

5,070.75

4,952.85

6,316.20

4,451.59

4,131.41

4,037.09

3,309.88

Other Operating Income

0.00

Total Operating income

5,070.75

4,952.85

6,316.20

4,451.59

4,131.41

4,037.09

3,309.88

Raw Material Cost

1,058.32

1,010.70

2,199.88

865.07

832.96

763.14

555.43

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

514.70

436.15

367.00

313.45

303.02

298.46

249.83

Selling and Distribution Expenses

49.28

45.93

82.66

54.55

52.32

50.16

40.90

Other Expenses

89.50

91.94

95.59

89.26

80.95

106.53

89.32

Total Expenditure (Excl Depreciation)

2,517.35

2,412.23

3,605.39

2,125.66

1,997.78

2,177.03

1,739.36

Operating Profit (PBDIT) excl Other Income

2553.4

2540.6

2710.7999999999997

2325.9

2133.6000000000004

1860.1

1570.5

Other Income

2.03

0.94

1.57

0.95

1.70

5.08

8.64

Operating Profit (PBDIT)

3,763.71

3,708.74

3,848.29

3,370.96

3,090.01

3,077.80

2,599.58

Interest

514.70

436.15

367.00

313.45

303.02

298.46

249.83

Exceptional Items

2.04

0.00

2.59

-1.57

0.76

-1.66

8.51

Gross Profit (PBDT)

2,804.15

2,774.97

2,980.41

2,542.44

2,343.76

2,359.75

1,983.87

Depreciation

1,208.28

1,167.18

1,135.91

1,044.08

954.69

914.20

770.58

Profit Before Tax

2,043.42

2,106.06

2,347.96

2,014.98

1,833.06

1,863.47

1,587.67

Tax

1.78

1.81

1.57

1.78

1.80

1.78

1.91

Provisions and contingencies

0.00

Profit After Tax

2,041.64

2,104.25

2,346.39

2,013.20

1,831.25

1,861.69

1,585.76

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

2,041.64

2,104.25

2,346.39

2,013.20

1,831.25

1,861.69

1,585.76

Share in Profit of Associates

0.00

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

2,041.64

2,104.25

2,346.39

2,013.20

1,831.25

1,861.69

1,585.76

Equity Capital

0.00

Face Value

0.0

Reserves

38,520.62

38,649.97

38,617.95

38,800.90

32,964.79

33,112.93

33,426.29

Earnings per share (EPS)

5679.1

5853.27

6526.83

5999.13

5888.26

5986.12

6167.05

Diluted Earnings per share

5679.1

5853.27

6526.83

5999.13

5888.26

5986.12

6167.05

Operating Profit Margin (Excl OI)

50.36%

51.3%

42.92%

52.25%

51.64%

46.07%

47.45%

Gross Profit Margin

64.13%

66.09%

55.16%

68.72%

67.48%

68.8%

71.25%

PAT Margin

40.26%

42.49%

37.15%

45.22%

44.33%

46.11%

47.91%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Annual Analysis Highlights

Net Sales

YoY Growth in year ended Jul 2025 is 2.38% vs -21.59% in Jul 2024

Consolidate Net Profit

YoY Growth in year ended Jul 2025 is -2.98% vs -10.32% in Jul 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Jul 2025 is 1.45% vs -3.61% in Jul 2024

Interest

YoY Growth in year ended Jul 2025 is 18.02% vs 18.83% in Jul 2024

Operating Profit Margin (Excl OI)

YoY Growth in year ended Jul 2025 has fallen from Jul 2024

Compare Annual Results Of Healthcare & Medical Investment Corp. With

Select Peers

Figures in Million

Consolidate Annual Results

Change(JPY)

Change(%)

Net Sales

5,070.75

9,295.30

-4,224.55

-45.45%

Other Operating Income

0.00

Total Operating income

5,070.75

9,295.30

-4,224.55

-45.45%

Raw Material Cost

1,058.32

1,914.69

-856.37

-44.73%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

514.70

752.50

-237.80

-31.60%

Selling and Distribution Expenses

49.28

70.58

-21.30

-30.18%

Other Expenses

89.50

300.97

-211.47

-70.26%

Total Expenditure (Excl Depreciation)

2,517.35

5,747.43

-3,230.08

-56.20%

Operating Profit (PBDIT) excl Other Income

2,553.40

3,547.87

-994.47

-28.03%

Other Income

2.03

9.84

-7.81

-79.37%

Operating Profit (PBDIT)

3,763.71

7,142.57

-3,378.86

-47.31%

Interest

514.70

752.50

-237.80

-31.60%

Exceptional Items

2.04

7.48

-5.44

-72.73%

Gross Profit (PBDT)

2,804.15

3,795.75

-991.60

-26.12%

Depreciation

1,208.28

3,584.86

-2,376.58

-66.29%

Profit Before Tax

2,043.42

2,812.68

-769.26

-27.35%

Tax

1.78

1.81

-0.03

-1.66%

Provisions and contingencies

0.00

Profit After Tax

2,041.64

2,810.87

-769.23

-27.37%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

2,041.64

2,810.87

-769.23

-27.37%

Share in Profit of Associates

0.00

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

2,041.64

2,810.87

-769.23

-27.37%

Equity Capital

0.00

Face Value

0.00

Reserves

38,520.62

44,217.40

-5,696.78

-12.88%

Earnings per share (EPS)

5,679.10

6,510.41

-831.31

-12.77%

Diluted Earnings per share

5,679.10

6,510.41

-831.31

-12.77%

Operating Profit Margin (Excl OI)

50.36%

38.17%

0.00

12.19%

Gross Profit Margin

64.13%

68.83%

0.00

-4.70%

PAT Margin

40.26%

30.24%

0.00

10.02%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Annual - Net Sales

Net Sales 507.07 Million

in Jul 2025

Figures in Million

YoY Growth in year ended Jul 2025 is 2.38% vs -21.59% in Jul 2024

Annual - Consolidate Net Profit

Consolidate Net Profit 204.16 Million

in Jul 2025

Figures in Million

YoY Growth in year ended Jul 2025 is -2.98% vs -10.32% in Jul 2024

Annual - Operating Profit (PBDIT)

Operating Profit (PBDIT) 376.17 Million

in Jul 2025

Figures in Million

YoY Growth in year ended Jul 2025 is 1.45% vs -3.61% in Jul 2024

Annual - Interest

Interest 51.47 Million

in Jul 2025

Figures in Million

YoY Growth in year ended Jul 2025 is 18.02% vs 18.83% in Jul 2024

Annual - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 50.36%

in Jul 2025

Figures in %

YoY Growth in year ended Jul 2025 has fallen from Jul 2024